Background: It is still unclear whether micrometastasis of para-aortic lymph nodes (PALNs) in pancreatic ductal adenocarcinoma (PDAC) is tantamount to PALN metastasis detected by hematoxylin and eosin (HE) staining. Methods: A total of 242 patients with PDAC who underwent radical pancreatectomy with PALN dissection were eligible for this study. Micrometastasis in PALNs was evaluated by CAM 5.2 immunohistochemistry. The relationship between PALN status and overall survival (OS) was analyzed. Results: Of the 242 enrolled patients, 25 (10 %) had PALN metastasis detected by HE (PALN HE-positive), and 21 (9 %) had PALN micrometastasis not detected by HE but identified by CAM 5.2 immunohistochemistry. Univariate analysis revealed that patients with PALN micrometastasis (p =.004) and PALN HE positivity (p =.003) had a significantly shorter OS than those without PALN metastasis, whereas no significant difference was observed between the two former groups (p =.874). In multivariate analysis, lack of adjuvant chemotherapy (hazard ratio [HR] 2.43, p
CITATION STYLE
Komo, T., Murakami, Y., Kondo, N., Uemura, K., Hashimoto, Y., Nakagawa, N., … Sueda, T. (2016). Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology, 23(6), 2019–2027. https://doi.org/10.1245/s10434-016-5120-8
Mendeley helps you to discover research relevant for your work.